Free Newsletter
Millipore in $1.6B makeover as life sciences supplier
Millipore is expanding on its reputation as a filtration supplier to scientific labs around the globe. Known for purified water and filters, Millipore has leveraged several buyouts to increase its offerings to a range of investigative tools for drug research. The company supplies a range of biopharma research operations, including investigators at Pfizer, Biogen Idec and Genzyme, according to a recent profile in the Boston Globe. In a bid to radically transform itself, Millipore went on a buying spree, acquiring Serologicals, Newport Bio Systems, NovAseptic and MicroSafe for more than $1.6 billion. And it's launched a marketing campaign to get the word out.
- see Millipore's release
- here's the article from The Boston Globe
Related Article:
Millipore to pay $1.4B for Serologicals. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: